Treatment of the morbidly obese diabetic patient in internal medicine

被引:0
|
作者
Wirth, A. [1 ]
机构
[1] Klin Teutoburger Wald, D-49214 Bad Rothenfelde, Germany
来源
DIABETOLOGE | 2008年 / 4卷 / 04期
关键词
obesity; diabetes mellitus; weight loss; lifestyle changes; anti-obesity drugs;
D O I
10.1007/s11428-008-0223-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In morbidly obese diabetics (BMI > 35 kg/m(2)) there is an urgent need for effective and long-lasting weight reduction for several reasons. Since the therapeutic target is a weight loss of > 10 kg a pronounced negative energy balance has to be induced. As far as adjustments in nutrition are concerned, a reduction in fat intake or an increased consumption of fruits and vegetables alone is not sufficient. The foodstuffs selected should be low in density and portion sizes should be reduced. Energy expenditure in leisure time activities should exceed 2000 kcal/week. This level of activity is often limited by co-morbidities in the muscular-skeletal and cardiovascular system. Since only extensive changes in lifestyle lead to therapeutic effects and given that most of the patients concerned will fail to reach this therapeutic goal, anti-obesity drugs have to be taken into consideration. Weight loss is most effective when foodstuffs with low energy density, endurance as well as resistance training, anti-obesity compounds, and group sessions are combined.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 50 条
  • [21] Surgery for Gastroesophageal Reflux Disease in the Morbidly Obese Patient
    Duke, Meredith C.
    Farrell, Timothy M.
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2017, 27 (01): : 12 - 18
  • [22] Hepatotoxicity after desflurane anesthesia in a morbidly obese patient
    Gabellini, Giulia
    Graziano, Alessandro
    Carron, Michele
    JOURNAL OF CLINICAL ANESTHESIA, 2018, 51 : 55 - 56
  • [23] Robotic Transabdominal Kidney Transplantation in a Morbidly Obese Patient
    Giulianotti, P.
    Gorodner, V.
    Sbrana, F.
    Tzvetanov, I.
    Jeon, H.
    Bianco, F.
    Kinzer, K.
    Oberholzer, J.
    Benedetti, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (06) : 1478 - 1482
  • [24] Pharmacokinetics of doxorubicin and etoposide in a morbidly obese pediatric patient
    Ritzmo, Carina
    Soderhall, Stefan
    Karlen, Jonas
    Nygren, Helen
    Eksborg, Staffan
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2007, 24 (5-8) : 437 - 445
  • [25] Laparoscopic gastric plication in the morbidly obese adolescent patient
    Vanguri, Poornima
    Brengman, Matthew
    Oiticica, Claudio
    Wickham, Edmond P., III
    Bean, Melanie K.
    Lanning, David A.
    SEMINARS IN PEDIATRIC SURGERY, 2014, 23 (01) : 24 - 30
  • [26] Massive localized lipolymphedema pseuotumor in a morbidly obese patient
    Jensen, V.
    Witte, M. H.
    Latifi, R.
    LYMPHOLOGY, 2006, 39 (04) : 181 - 184
  • [27] Therapeutic drug monitoring of vancomycin in a morbidly obese patient
    Penzak, SR
    Gubbins, PO
    Rodvold, KA
    Hickerson, GL
    THERAPEUTIC DRUG MONITORING, 1998, 20 (03) : 261 - 265
  • [28] The Fate of Morbidly Obese Patients With Joint Pain: A Retrospective Study of Patient Outcomes
    Reeves, Russell A.
    Hefter, Glenn D.
    Pellegrini, Vincent D., Jr.
    Drew, Jacob M.
    Barfield, William R.
    Demos, Harry A.
    JOURNAL OF ARTHROPLASTY, 2021, 36 (09) : 3101 - +
  • [29] Outcomes of Total Knee Arthroplasty Revisions in Obese and Morbidly Obese Patient Populations
    Bigham, William R.
    Lensing, Gabriel S.
    Walters, Murphy M.
    Bhanat, Eldrin
    Keeney, James A.
    Stronach, Benjamin M.
    JOURNAL OF ARTHROPLASTY, 2023, 38 (09) : 1822 - 1826
  • [30] The obese patient and emergency medicine
    S. W. Hauschild
    S. Wirtz
    N. Köster
    W. Nölken
    Notfall & Rettungsmedizin, 2005, 8 (3): : 207 - 215